Data mining for potential adverse drug-drug interactions

Expert Opinion on Drug Metabolism and Toxicology

Volumn 10, Issue 5, 2014, Pages 665-671

  Hammann, Felix ^a   Drewe, Juergen ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adverse drug reaction; Drug drug interaction; QSAR

Indexed keywords

ABC TRANSPORTER; AMOXICILLIN; BENSERAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CAPTOPRIL; CEPHALOSPORIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLAVULANIC ACID; CYTOCHROME P450 1A2; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; CYTOCHROME P450 INHIBITOR; DOMPERIDONE; DRUG METABOLIZING ENZYME; GLUCURONOSYLTRANSFERASE; LEVODOPA; LITHIUM; LORAZEPAM; METOCLOPRAMIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PAROXETINE; PENICILLIN DERIVATIVE; PROBENECID; THIAZIDE DIURETIC AGENT; XENOBIOTIC AGENT;

ADVERSE DRUG REACTION; AEROBIC METABOLISM; ALGORITHM; BLOOD BRAIN BARRIER; COMPUTER PROGRAM; DATA MINING; DRUG ABSORPTION; DRUG CLEARANCE; DRUG EFFICACY; DRUG ELIMINATION; DRUG INTERACTION; DRUG METABOLISM; DRUG PENETRATION; DRUG POTENTIATION; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; ELECTRONIC MEDICAL RECORD; GASTROINTESTINAL TRANSIT; GENETIC POLYMORPHISM; GERIATRIC PATIENT; HUMAN; INTERNET; KIDNEY FUNCTION; MEDICAL INFORMATICS; MEDLINE; MEMBRANE PERMEABILITY; NATURAL LANGUAGE PROCESSING; POLYPHARMACY; PREDICTION; REVIEW; RISK ASSESSMENT; SEARCH ENGINE; BIOLOGICAL MODEL; CLINICAL PHARMACOLOGY; GERIATRICS; PROCEDURES; TRENDS;

DATA MINING; DRUG INTERACTIONS; GERIATRICS; HUMANS; MODELS, BIOLOGICAL; PHARMACOLOGY, CLINICAL; PHARMACOVIGILANCE;

EID: 84898444176     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2014.894507     Document Type: Review

References (44)

1. Kola I, Landis J. Can the pharmaceutical industry reduce attrition rates? Nat Rev Drug Discov 2004;3(8):711-15
2. van de Waterbeemd H, Gifford E. ADMET in silico modelling: towards prediction paradise? Nat Rev Drug Discov 2003;2(3):192-204
3. Zhou S. Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. Curr Drug Metab 2008;9(4):310-22
4. Shimada T, Yamazaki H, Mimura M, et al. Interindividual variations in human liver cytochrome-P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals-studies with liver-microsomes of 30 japanese and 30 caucasians. J Pharmacol Exp Ther 1994;270(1):414-23
5. Guengerich FP. Cytochrome p450 and chemical toxicology. Chem Res Toxicol 2008;21(1):70-83
6. Lindblad CI, Hanlon JT, Gross CR, et al. Clinically important drug-disease interactions and their prevalence in older adults. Clin Ther 2006;28(8):1133-43
7. European Medicines Agency. European Database of Suspected Adverse Drug Reaction Reports. 2013. Available from: http://www.adrreports.eu/[Last accessed January 2014]
8. Tatonetti NP, Denny JC, Murphy SN, et al. Detecting drug interactions from adverse-event reports: interaction between paroxetine and pravastatin increases blood glucose levels. Clin Pharmacol Ther 2011;90(1):133-42
9. Harpaz R, Haerian K, Chase HS, Friedman C. Statistical mining of potential drug interaction adverse effects in FDA's spontaneous reporting system. AMIA Annu Symp Proc 2010;2010:281-5
10. Health Canada. Adverse Reaction Database. Government of Canada. 2014. Available from: http://www.hc-sc. gc.ca/dhp-mps/medeff/databasdon/index-eng.php [Last accessed January 2014]
11. Micromedix 2.0., Truven Health Analytics. Available from: http://www.micromedex. com/[Last accessed January 2014]
12. Drug interactions. Indiana University, Division of Clinical Pharmacology. Available from: http://medicine.iupui.edu/clinpharm/ddis/[Last accessed January 2014]
13. Leone R, Magro L, Moretti U, et al. Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in italy. Drug Saf 2010;33(8):667-75
14. Duda S, Aliferis C, Miller R, et al. Extracting drug-drug interaction articles from MEDLINE to improve the content of drug databases. AMIA Annu Symp Proc 2005;216-20
15. Krallinger M, Erhardt RAA, Valencia A. Text mining approaches in molecular biology and biomedicine. Drug Discov Today 2005;10(6):439-45
16. Segura-Bedmar I, Martinez P, de Pablo-Sanchez C. A linguistic rule-based approach to extract drug-drug interactions from pharmacological documents. BMC Bioinformatics 2011;12(Suppl 2):S1-S11
17. Huang ML, Zhu XY, Li M. A hybrid method for relation extraction from biomedical literature. Int J Med Inform 2006;75(6):443-55
18. Percha B, Garten Y, Altman RB. Discovery and explanation of drug-drug interactions via text mining. Pac Symp Biocomput 2012;410-21
19. Wishart DS, Knox C, Guo AC, et al. DrugBank: a knowledgebase for drugs, drug actions and drug targets. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/18048412 [Last accessed January 2014]
20. Sedykh A, Fourches D, Duan J, et al. Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res 2013;30(4):996-1007
21. PharmGKB. The Pharmacogenomics Knowledgebase. Stanford University. 2014. Available from: http://www. pharmgkb.org/[Last accessed January 2014]
22. Merle L, Laroche M-L, Dantoine T, Charmes J-P. Predicting and preventing adverse drug reactions in the very old. Drugs Aging 2005;22(5):375-92
23. Klotz U, Avant GR, Hoyumpa A, et al. The effects of age and liver disease on the disposition and elimination of diazepam in adult man. J Clin Invest 1975;55(2):347-59
24. Zakrzewski-Jakubiak H, Doan J, Lamoureux P, et al. Detection and prevention of drug-drug interactions in the hospitalized elderly: utility of new cytochrome P450-based software. Am J Geriatr Pharmacother 2011;9(6):461-70
25. Egger T, Dormann H, Ahne G, et al. Identification of adverse drug reactions in geriatric inpatients using a computerised drug database. Drug Aging 2003;20(10):769-76
26. Hasan M, Woodhouse K. The accuracy of information on current drug therapy in geriatric out-patients' records. Arch Gerontol Geriatr 1996;22(1):21-5
27. Pearson RM. Who is taking their tablets. Br Med J (Clin Res Ed) 1982;285(6344):757-8
28. Fiss T, Ritter CA, Alte D, et al. Detection of drug related problems in an interdisciplinary health care model for rural areas in Germany. Pharm World Sci 2010;32(5):566-74
29. Choi CA, Chang MJ, Choi HD, et al. Application of a drug-interaction detection method to the korean national health insurance claims database. Regul Toxicol Pharmacol 2013;67(2):294-8
30. Noren GN, Sundberg R, Bate A, Edwards IR. A statistical methodology for drug-drug interaction surveillance. Stat Med 2008;27(16):3057-70
31. Qian Y, Ye X, Du W, et al. A computerized system for detecting signals due to drug-drug interactions in spontaneous reporting systems. Br J Clin Pharmacol 2010;69(1):67-73
32. Duke JD, Han X, Wang Z, et al. Literature based drug interaction prediction with clinical assessment using electronic medical records: novel myopathy associated drug interactions. PLoS Comput Biol 2012;8(8):e1002614
33. Yamashita F, Feng C, Yoshida S, et al. Automated information extraction and structure-activity relationship analysis of cytochrome P450 substrates. J Chem Inf Model 2011;51(2):378-85
34. Takarabe M, Shigemizu D, Kotera M, et al. Network-based analysis and characterization of adverse drug-drug interactions. J Chem Inf Model 2011;51(11):2977-85
35. Hu TM, Hayton WL. Architecture of the drug-drug interaction network. J Clin Pharm Ther 2011;36(2):135-43
36. Stockley S. Drug interactions: a source book of adverse interactions, their mechanisms, clinical importance and management. 2nd edition. Blackwell Scientific Publcations, Oxford; 1991
37. Batagelj V, Mrvar A. Pajek: a program for large network analysis. Connections 1998.21:47-57. Available from: http://vlado.fmf.uni-lj.si/pub/ networks/pajek/[Last accessed November 2013]
38. KEGG. KEGG (Kyoto Encyclopedia of Genes and Genomes) Drug. 2013. Available from: http://www.genome.jp/kegg/drug/[Last accessed January 2014]
39. JAPIC. Japan Pharmaceutical Information Center. Available from: http://www.japic. or.jp/[Last accessed January 2014]
40. International language for drug utilization research. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, Nydalen, Oslo, Norway. 2014. Available from: http://www.whocc.no/[Last accessed January 2014]
41. Zhang Y, Lin H, Yang Z, et al. A single kernel-based approach to extract drug-drug interactions from biomedical literature. PLoS One 2012;7(11):e48901
42. . SEM); 14-15 June 2013; Atlanta, Georgia; 2013. p. 241-50
43. Strandell J, Caster O, Hopstadius J, et al. The development and evaluation of triage algorithms for early discovery of adverse drug interactions. Drug Saf 2013;36(5):371-88
44. White RW, Tatonetti NP, Shah NH, et al. Web-scale pharmacovigilance: listening to signals from the crowd. J Am Med Inform Assoc 2013;20(3):404-8